The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125728711 12572871 1 I 20160718 20160720 20160720 EXP IN-ROCHE-1797437 ROCHE , PUNATAR S, MATHEW L, KANNAN S AND KHATTRY N FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINICAL OUTCOME IN ACUTE LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION 2016;32 (3):248-256. 0.00 Y 0.00000 20160720 OT IN IN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125728711 12572871 1 PS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 Oral U 50722 CAPSULE
125728711 12572871 2 SS CYCLOSPORINE A CYCLOSPORINE 1 Intravenous (not otherwise specified) AS 2 H INFUSION U 0 INFUSION BID
125728711 12572871 3 SS CYCLOSPORINE A CYCLOSPORINE 1 Oral U 0
125728711 12572871 4 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125728711 12572871 1 Prophylaxis against graft versus host disease
125728711 12572871 2 Prophylaxis against graft versus host disease
125728711 12572871 4 Prophylaxis against graft versus host disease

Outcome of event

Event ID CASEID OUTC COD
125728711 12572871 OT
125728711 12572871 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125728711 12572871 Diarrhoea
125728711 12572871 Hypertension
125728711 12572871 Mucosal inflammation
125728711 12572871 Nephropathy toxic
125728711 12572871 Neurotoxicity
125728711 12572871 Neutropenic sepsis
125728711 12572871 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found